The role of living‐donor liver transplantation in children with an advanced malignant rhabdoid tumor of the liver in the era of transplant oncology: Case report and literature review

Yanagi, Yusuke; Sakamoto, Seisuke; Nakao, Toshimasa; Kodama, Tasuku; Uchida, Hajime; Shimizu, Seiichi; Fukuda, Akira; Yamada, Masaki; Kiyotani, Chikako; Matsumoto, Kimikazu; Yoshioka, Takako; Miyazaki, Osamu; Nosaka, Shunsuke; Kasahara, Mureo

doi:10.1002/pbc.30582

Pediatric Blood & Cancer

2023

DOI: 10.1002/pbc.30582

|View full text |Cite

The role of living‐donor liver transplantation in children with an advanced malignant rhabdoid tumor of the liver in the era of transplant oncology: Case report and literature review

Yusuke Yanagi

Seisuke Sakamoto

Toshimasa Nakao

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Liver transplantation for pediatric liver malignancies

Sakamoto,

Harikrishnan,

Uchida

et al. 2024

Liver Transplantation

View full text Add to dashboard Cite

In the last few decades, collaboration between the international pediatric oncology groups has resulted in significant improvement in survival after liver transplantation (LT) for pediatric liver tumors, and LT has become the accepted standard of care for unresectable pediatric liver tumors – either living donor liver transplantation (LDLT) or deceased donor liver transplantation (DDLT). Hepatoblastoma (HB) and hepatocellular carcinoma (HCC) are the common pediatric liver malignancies treated by LT, and LT is now the accepted treatment modality for unresectable non-metastatic cases. The long-term survival rate is more than 80% in HB transplants. Furthermore, with the advent of LDLT, the waitlist mortality, availability of a better graft quality with shorter ischemic times, and performance of LT with the appropriate timing between chemotherapy have all improved. Up to 80% of pediatric HCCs are unresectable, and studies have shown that LT for pediatric HCC has better outcomes than liver resection. Furthermore, LT has also shown better results than liver resection for cases of HCC not meeting Milan criteria. Given the rarity of pediatric liver malignancies and challenges in optimal management, a multidisciplinary treatment approach, research models building on what is already known, and consideration of newer treatment modalities are required for further improving the treatment of pediatric liver malignancies.

show abstract

Liver transplantation for pediatric liver malignancies

Sakamoto,

Harikrishnan,

Uchida

et al. 2024

Liver Transplantation

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The role of living‐donor liver transplantation in children with an advanced malignant rhabdoid tumor of the liver in the era of transplant oncology: Case report and literature review

Cited by 1 publication

References 20 publications

Liver transplantation for pediatric liver malignancies

Liver transplantation for pediatric liver malignancies

Contact Info

Product

Resources

About